Serum levels of soluble receptor for advanced glycation end products and of S100 proteins are associated with inflammatory, autoantibody, and classical risk markers of joint and vascular damage in rheumatoid arthritis
-
* Corresponding author: Ranjeny Thomas r.thomas1@uq.edu.au
Arthritis Research & Therapy 2009, 11:R39 doi:10.1186/ar2645
Accesses
- Last 30 days: 95 accesses
- Last 365 days: 933 accesses
- All time: 4101 accesses
Cited by
BioMed Central: 1 citation
|
Lucie Andrés Cerezo, Heřman Mann, Ondřej Pecha, Lenka Pleštilová, Karel Pavelka, Jiří Vencovský, Ladislav Šenolt Arthritis Research & Therapy 2011, 13:R122 (26 July 2011) |